Suppr超能文献

益生菌和营养物质在功能性胃肠疾病中的疗效:一项初步临床试验

Efficacy of probiotics and nutrients in functional gastrointestinal disorders: a preliminary clinical trial.

作者信息

S Kim Linda, Hilli Lisa, Orlowski Jennifer, Kupperman Jami L, Baral Matthew, F Waters Robert

机构信息

Southwest College Research Institute, Southwest College of Naturopathic Medicine & Health Sciences, 2140 East Broadway Road, Tempe, Arizona 85282-1751, USA.

出版信息

Dig Dis Sci. 2006 Dec;51(12):2134-44. doi: 10.1007/s10620-006-9297-8. Epub 2006 Nov 1.

Abstract

The purpose of this study was to evaluate the efficacy and safety of commonly used probiotics and nutrients available for functional gastrointestinal disorders (FGID). Five different combinations of probiotics and nutrients, or placebo, were taken daily over 12 weeks. In this randomized controlled clinical trial, men and women 21 to 72 years of age with FGID symptoms of indigestion, bloating, and abdominal discomfort were assigned to one of six groups, 12 patients per group. Gastrointestinal Quality of Life Index (GIQLI) and visual analogue scale (VAS) for GI symptoms, SF-36, lactulose and mannitol test (LMT), and urine indican levels were evaluated. GIQLI, VAS scores, and LMT did not change significantly (P > 0.05). There were clinically notable improvements in two of the combination formulations. While the nonsignificant improvements in GI symptoms could suggest that combination probiotics and nutrients may be beneficial in conditions such as FGID, no conclusive evidence was found in this pilot trial. Further investigations to explore the findings are discussed.

摘要

本研究的目的是评估常用于功能性胃肠病(FGID)的益生菌和营养素的疗效及安全性。在12周的时间里,每天服用五种不同组合的益生菌和营养素或安慰剂。在这项随机对照临床试验中,年龄在21至72岁、有消化不良、腹胀和腹部不适等FGID症状的男性和女性被分为六组,每组12名患者。评估了胃肠道生活质量指数(GIQLI)、胃肠道症状视觉模拟量表(VAS)、SF-36、乳果糖和甘露醇试验(LMT)以及尿靛基质水平。GIQLI、VAS评分和LMT均无显著变化(P>0.05)。两种组合制剂有临床上值得注意的改善。虽然胃肠道症状的非显著改善可能表明联合益生菌和营养素在FGID等病症中可能有益,但在这项初步试验中未发现确凿证据。讨论了进一步探究这些发现的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验